Scientist

Tevogen Bio Announces Partnership With BioCentriq, New Jersey Innovation Institute’s Pioneering Cell and Gene Therapy Center, to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19

Carly Wronko

METUCHEN, N.J.–(BUSINESS WIRE)–Tevogen Bio announces partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment. Under the partnership, experts from both entities will collaborate at BioCentriq’s state-of-the art GMP facilities to produce Tevogen’s proprietary COVID-19 targeted T cells. The teams will utilize the processes and technology …

Code written on a screen

App security platform provider Pathlock raises $20M

Carly Wronko

Unified access orchestration platform provider Pathlock, formerly Greenlight Technologies, today announced it has secured $20 million in a strategic growth round led by Vertica Capital Partners. Pathlock says the funds will be used to bolster R&D for its products, extending the capabilities of its insider threat prevention platform. According to Markets and Markets, the security orchestration, automation, and response (SOAR) segment is …

Atlantic city international airport

NASA touches down in Atlantic County, collaborates with FAA

Carly Wronko

EGG HARBOR TOWNSHIP — NASA made one giant leap into South Jersey by teaming up with the Federal Aviation Administration William J. Hughes Technical Center to collaborate on advancing drone technology, electric vertical takeoff and landing aircraft operating in low-altitude airspace in urban environments. Under a multiyear agreement, NASA will use work space at the FAA’s National Aviation Research and Technology …

BIRD Energy to invest $7.5 Million in Cooperative Israel-U.S. Clean Energy Projects

Carly Wronko

The total value of the approved projects is $17.4 million in the areas of Batteries, Electric Aircraft, Fuel Cells, Electric Vehicles, Natural Gas, Wind Energy and Energy Efficiency The U.S. Department of Energy (DOE) and Israel’s Ministry of Energy (MoE) along with the Israel Innovation Authority have selected eight clean energy projects to receive $7.15 million under the Binational Industrial …

COVID-19 image

BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment

Carly Wronko

North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …

Scientist inspects testtube

Hackensack Meridian CDI, Merck to Collaborate on COVID-19 Research

Carly Wronko

The collaborative work aims to find drugs to treat the pandemic The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic. “The CDI was started less than a year ago to provide dynamic research …

Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

Carly Wronko

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

COVID-19 test being held in a lab.

PTC Therapeutics taps experimental cancer drug for new COVID-19 trial

Carly Wronko

PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease. It is any day now kick-starting a phase 2/3 trial …

lab worker

New Jersey Solutions For Cell And Gene Development and Manufacturing

Carly Wronko

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …